Modulation of cancer pathways by inhibitors of guanylate metabolism.
Oláh
Edith
E
Department of Molecular Genetics, National Institute of Oncology, Ráth György utca 7, Budapest 1122, Hungary. e.olah@oncol.hu
Kökény
Szabolcs
S
Papp
János
J
Bozsik
Anikó
A
Keszei
Márton
M
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D006157:Guanosine Monophosphate / Q000378:metabolism*; D006801:Humans; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors*; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D012254:Ribavirin / Q000031:analogs & derivatives / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D012254:Ribavirin; D006157:Guanosine Monophosphate; D007168:IMP Dehydrogenase; C033706:tiazofurin